Jeffrey S. Parkin

Array ( [id] => 4765582 [patent_doc_number] => 20080176794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 11/877300 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30226 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176794.pdf [firstpage_image] =>[orig_patent_app_number] => 11877300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872749 [patent_doc_number] => 20080199483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 11/877221 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30221 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199483.pdf [firstpage_image] =>[orig_patent_app_number] => 11877221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892987 [patent_doc_number] => 20080102085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV' [patent_app_type] => utility [patent_app_number] => 11/874552 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18389 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102085.pdf [firstpage_image] =>[orig_patent_app_number] => 11874552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4517871 [patent_doc_number] => 07939083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain' [patent_app_type] => utility [patent_app_number] => 12/312016 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 27 [patent_no_of_words] => 55312 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939083.pdf [firstpage_image] =>[orig_patent_app_number] => 12312016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7739550 [patent_doc_number] => 08105610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Method of making novel erythrovirus V9 VP2 capsid polypeptides' [patent_app_type] => utility [patent_app_number] => 11/868380 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 8354 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105610.pdf [firstpage_image] =>[orig_patent_app_number] => 11868380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420809 [patent_doc_number] => 20100150960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/442483 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24277 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150960.pdf [firstpage_image] =>[orig_patent_app_number] => 12442483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373728 [patent_doc_number] => 20090311289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/310966 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 49069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311289.pdf [firstpage_image] =>[orig_patent_app_number] => 12310966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7534809 [patent_doc_number] => 08048431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domain' [patent_app_type] => utility [patent_app_number] => 11/896934 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 227 [patent_figures_cnt] => 302 [patent_no_of_words] => 21413 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048431.pdf [firstpage_image] =>[orig_patent_app_number] => 11896934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152495 [patent_doc_number] => 08168772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling' [patent_app_type] => utility [patent_app_number] => 11/897320 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 126607 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168772.pdf [firstpage_image] =>[orig_patent_app_number] => 11897320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431465 [patent_doc_number] => 20100143402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'INTERGENIC SITES BETWEEN CONSERVED GENES IN THE GENOME OF MODIFIED VACCINIA ANKARA (MVA) VACCINIA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/377847 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 17214 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143402.pdf [firstpage_image] =>[orig_patent_app_number] => 12377847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302391 [patent_doc_number] => 20100068217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'EPITOPE-TRANSPLANT SCAFFOLDS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/438913 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 30731 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12438913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4594983 [patent_doc_number] => 07981430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome' [patent_app_type] => utility [patent_app_number] => 11/844301 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 35694 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981430.pdf [firstpage_image] =>[orig_patent_app_number] => 11844301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718613 [patent_doc_number] => 20080241135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Methods for reducing viral load in HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 11/894762 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 31458 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241135.pdf [firstpage_image] =>[orig_patent_app_number] => 11894762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080276 [patent_doc_number] => 20110142911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'HIV epitopes and pharmaceutical composition containing same' [patent_app_type] => utility [patent_app_number] => 11/894172 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142911.pdf [firstpage_image] =>[orig_patent_app_number] => 11894172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785568 [patent_doc_number] => 20080138897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method for preventing HIV-1 infection of CD4+ Cells' [patent_app_type] => utility [patent_app_number] => 11/894568 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12002 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138897.pdf [firstpage_image] =>[orig_patent_app_number] => 11894568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290060 [patent_doc_number] => 20100158945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'ATTENUATED POLIO VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/377041 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5665 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158945.pdf [firstpage_image] =>[orig_patent_app_number] => 12377041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955616 [patent_doc_number] => 20080188640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Immunodeficiency recombinant poxvirus' [patent_app_type] => utility [patent_app_number] => 11/891027 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 129 [patent_figures_cnt] => 129 [patent_no_of_words] => 49012 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188640.pdf [firstpage_image] =>[orig_patent_app_number] => 11891027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687691 [patent_doc_number] => 20080031872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'HIV immunogenic composition and method of administration' [patent_app_type] => utility [patent_app_number] => 11/888471 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4620 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031872.pdf [firstpage_image] =>[orig_patent_app_number] => 11888471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797131 [patent_doc_number] => 20080008717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus' [patent_app_type] => utility [patent_app_number] => 11/828272 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13546 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008717.pdf [firstpage_image] =>[orig_patent_app_number] => 11828272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191541 [patent_doc_number] => 09422342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Recoding method that removes inhibitory sequences and improves HIV gene expression' [patent_app_type] => utility [patent_app_number] => 12/373605 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17863 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373605 [rel_patent_id] =>[rel_patent_doc_number] =>)